Whether tumours can co-opt GSH catabolism to fuel their growth is poorly understood
The question is no longer whether high-volume automation pays for itself on traditional oral solids
What foods are easiest when side effects are bad
Many patients find that supportive strategies like proper hydration, gut health support, and working closely with their provider can help manage these effects effectively
Tirzepatide (Mounjaro) is a dual agonist targeting both GLP-1 and GIP receptors, which tends to produce greater weight loss
The Cost Challenge: Understanding and Managing GLP-1 Costs Despite their effectiveness, GLP-1s are among the most expensive weight loss interventions, with costs ranging from $1,000 to $1,500 per month per patient